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Abstract
Spaceflight affects numerous organ systems in the body, leading to metabolic dysfunction
that may have long-term consequences. Microgravity-induced alterations in liver metabo-
lism, particularly with respect to lipids, remain largely unexplored. Here we utilize a novel
systems biology approach, combining metabolomics and transcriptomics with advanced
Raman microscopy, to investigate altered hepatic lipid metabolism in mice following short
duration spaceflight. Mice flown aboard Space Transportation System -135, the last Shuttle
mission, lose weight but redistribute lipids, particularly to the liver. Intriguingly, spaceflight
mice lose retinol from lipid droplets. Both mRNA and metabolite changes suggest the retinol
loss is linked to activation of PPARα-mediated pathways and potentially to hepatic stellate
cell activation, both of which may be coincident with increased bile acids and early signs of
liver injury. Although the 13-day flight duration is too short for frank fibrosis to develop, the
retinol loss plus changes in markers of extracellular matrix remodeling raise the concern
that longer duration exposure to the space environment may result in progressive liver dam-
age, increasing the risk for nonalcoholic fatty liver disease.
Introduction
The spaceflight environment impacts many physiological systems, resulting in potentially seri-
ous consequences, particularly for longer duration space exploration. As use of the Interna-
tional Space Station (ISS) is increased, and with the rise of commercial spaceflight and tourism,
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the systemic effects of microgravity must be carefully investigated to protect human health.
Although most research has focused on bone, muscle, brain and cardiovascular function, sev-
eral studies have shown that exposure to the space environment alters both energy and lipid
metabolism in humans and rodents [1, 2]. In astronauts, a diabetogenic phenotype was
induced, the severity of which was linked with flight duration [1, 3], suggesting the liver may be
a target of spaceflight-induced deficits. Indeed, significant spaceflight-induced changes in
hepatic genes linked to oxidative defense have been previously observed [4].
The liver is a major metabolic organ and the most common chronic disease worldwide
affecting the liver is nonalcoholic fatty liver disease (NAFLD). NAFLD describes a spectrum
of liver abnormalities, ranging from hepatic steatosis, or fat droplet accumulation, to nonal-
coholic steatohepatitis (NASH), with inflammation and fibrosis causing irreversible tissue
damage in many cases. NAFLD increases the risk of cardiovascular events eight-fold, type 2
diabetes mellitus three-fold, and is a strong risk factor for hepatocellular carcinoma [5]. The
molecular mechanisms underlying this phenotype are not well understood and whether the
liver is vulnerable to injury or dysfunction resulting from spaceflight remains an open
question.
Direct cellular contact and dynamic biochemical signaling modulate crosstalk between
endothelial cells, hepatic stellate cells (HSCs), Kupffer cells and hepatocytes, therefore damage
to any of these cells may disrupt homeostasis and lead to NAFLD. The development of NAFLD
is still poorly understood; however, several insults (“hits”) are thought to be jointly responsible
for causing progressive liver injury. The “classical” hit typically involves excessive triglyceride
accumulation in the hepatocytes and resultant dysfunction due to subsequent hits from oxida-
tive stress, lipotoxicity or gut-derived bacterial endotoxin activation of Kupffer cells, inducing
secretion of pro-inflammatory cytokines that activate neighboring HSCs [6, 7]. Activated
HSCs then fill the Space of Disse with extracellular matrix (ECM), further diminishing hepato-
cyte function and setting about a positive feed-back loop that progressively diminishes hepato-
cyte function and nutrient availability.
The goal of this study was to more comprehensively characterize molecular and functional
changes in the liver, some of which may represent early signs of NAFLD, which result from
spaceflight. In liver, chronic hyperlipidemia and stress can cause activation of HSCs [8]. HSCs
play an important role in the pathogenesis of liver disease and the activation of HSCs, a process
involving retinoid export followed by transformation into proliferative myofibroblasts and col-
lagen secretion, represents a final common pathway in the response of the liver to insult or
injury. A characteristic of healthy HSCs is the storage of retinyl esters in multiple lipid droplets.
Repeated hepatic insult due to excess lipid storage has been linked with the increasing loss of
HSC lipid droplets and their retinoid stores, accompanied by progressively worsening hepatic
fibrosis [9]. Notably, oxidative stress, an important and well-known component of the space
environment, can activate HSCs [10], a major step in the pathway to NAFLD [11].
Utilizing a novel, multi-faceted systems biology approach and liver samples obtained from
placebo-treated mice aboard Space Transportation System (STS) -135, the final 13-day US
Space Shuttle mission launched on July 8, 2011, we observed changes in hepatic pathophysiol-
ogy of spaceflight mice suggestive of early NAFLD. We also observed activation of a self-main-
taining peroxisome proliferator-activated receptor (PPAR) alpha-driven program mediated by
thioesterases, generating ω-3 fatty acids, ketone bodies, bile acids and dicarboxylic acids.
Increased hepatic collagen deposition was not observed in mice subjected to this short-dura-
tion spaceflight; however, we observed profound loss of retinol and altered mRNA expression
levels of several markers of HSC activation, raising the concern that a NAFLD-like phenotype
that may become pathogenic might follow prolonged exposure to the space environment.
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Materials and Methods
The University of Colorado Anschutz Medical Campus Institutional Animal Care and Use
Committee (IACUC) was consulted for our portion of the study and no protocol was required,
since only tissues obtained after euthanasia (no live animals) were analyzed at our site. All
NASA studies involving vertebrate animals are carried out in strict accordance with the recom-
mendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes
of Health. The animal studies performed were reviewed and approved by multiple ACUC
boards, including the NASA Ames Research Center ACUC, the NASA Kennedy Space Center
(KSC) ACUC and the University of Colorado at Boulder IACUC (the home institution for the
Principal Investigator of the overarching study–Dr. V. L. Ferguson), following NASA’s stan-
dard operating procedures.
Animals and Sample Collection
Nine-week old weight-matched female C57BL/6J mice (n = 15/group) were placed into three
Animal Enclosure Modules (AEMs, 2 groups of 5 per AEM separated by a wire mesh) and
flown on the Space Shuttle Atlantis (STS-135) for approximately 13.5 days. Ground AEM con-
trols (n = 15) were housed at the Space Life Science Laboratory (SLSL) at KSC. Females were
selected because they produce fewer odor annoyance issues and were the only gender approved
for flight, principally with the numbers of animals being flown (10 per habitat, 5 per side).
Additionally, all historical data (e.g., STS-118) were obtained on female mice so it permitted
comparisons across missions, particularly for the musculoskeletal studies that were primary.
Upon receipt, all mice were provided sterilized Purina Lab Diet 5K52 (22.2% protein, 16.0%
fat, 61.7% carbohydrates, caloric density 3.17 kcal/g) ad libitum in the food hopper and a
NASA NuRFB foodbar was provided on the floor of the cage. Two days later the Purina diet
was removed. Only the NASA NuRFB foodbar (2.80 kcal/g) was provided from that point for-
ward. The NASA NuRFB powdered diet is custom ordered from Harlan Teklad (TD 04197)
and is comprised of 47% carbohydrate, 17.9% protein, 3.9% lipids, 2.8% fiber, and 28% water.
Long and short-term ground studies show no difference in physiological response between
mice fed the NuRFB vs. the AIN-93G Growth Purified Diet recommended by the American
Institute of Nutrition (18.7% protein, 16.4% fat, 65.1% carbohydrates, 3.89 kcal/g) [12, 13].
AEM control mice were placed into the same housing used in flight and environmental param-
eters were matched as closely as possible based on 48-hour delayed telemetry data. Conditions
were controlled for temperature, humidity, and a 12:12 hr light:dark cycle; NASA foodbars and
water were provided ad libitum. All mice were placed into AEM housing one day before flight.
All mice underwent dual-energy X-ray absorptiometry (DXA) densitometry (Piximus) both
pre- and post-flight. Mice were anesthetized briefly with isoflurane (< 10 minutes under anes-
thesia) and allowed to recover following DXA (preflight) or were immediately euthanized
(postflight).
Tissues were distributed across a large team of investigators under the guidance/organiza-
tion of NASA’s Biospecimen Sharing Program; we received one half lobe of liver from six mice
per group. All dissections occurred at the SLSL within 3–5 h after return of the Space Shuttle
Atlantis. Mice, approximately 11 weeks of age, were euthanized using 4% isoflurane followed
by cardiac puncture and exsanguination. Liver lobes were extracted and dissected. A portion of
the liver was prepared in 4% paraformaldehyde and the rest snap frozen in liquid nitrogen.
Snap frozen and fixed livers were shipped to either Loma Linda University or University of
Colorado Anschutz Medical Campus and stored appropriately prior to use. One fixed AEM
liver did not provide useful sections and was not included in imaging analyses. Fat depots were
dissected, weighed and flash frozen then stored at -80°C.
Spaceflight and NAFLD
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Transcriptomics
A detailed description is provided in S1 File. Briefly, RNA was isolated with an RNeasy kit
(Qiagen) and the Ambion WT expression kit was employed to prepare mRNA for whole tran-
scriptome microarray analysis using an Affymetrix GeneChip 1.0ST array. Arrays were
scanned using GeneChip Scanner 3000 7G and Command Console Software v. 3.2.3 to pro-
duce.CEL intensity files which were processed with CARMAweb. Results were imported into
Ingenuity Pathway Analysis (Qiagen) software.
Quantitative Real-Time PCR
RNA was isolated using an RNeasy kit as above and quantified using a NanoDrop spectropho-
tometer (NanoDrop Technologies). RNA was converted to cDNA using reverse transcriptase
reagents (Bio-Rad Laboratories). Candidate gene expression was analyzed using the TaqMan
and SYBR system based on real-time detection of accumulated fluorescence (ABI Prism Step
One) as described previously [14]. Gene expression of each target sequence was normalized to
expression of the endogenous control 18S rRNA. Forward and reverse sequences for primers
used were as follows:
mPPARa-F: TCGCTATCCAGGCAGAAGG
mPPARa-R: AACAACAATAACCACAGA
m18s-F: TCCGATAACGAACGAGAC
m18s-R: CTAAGGGCATCACAGACC
Total Triglyceride Analysis
Frozen liver (~ 25 mg, n = 6/group) was used for analysis of total triglyceride content. Lipids
were extracted using 1:2:0.8 methanol:chloroform:water, dried under nitrogen, then resus-
pended in isopropyl alcohol with 2% Triton. Lipid extracts were mixed 1:100 with Infinity
Reagent (Thermo Fisher Scientific) and triglycerides quantified using a colorimetric assay fol-
lowing manufacturer’s instructions.
Metabolomics
Frozen liver pieces (n = 6/group) were sent to Metabolon, Inc. and stored at -80°C before use.
Samples were prepared for the appropriate instrument, either LC/MS or GC/MS, as described
previously [15, 16]. Briefly, automated sample preparation was conducted using a series of pro-
prietary organic and aqueous extractions. The resulting extract, including QC standards, was
divided into two fractions—one for analysis by LC and one for analysis by GC. Extracts were
placed briefly on a TurboVap1 (Zymark) to remove the organic solvent. Each extract was
then frozen and dried under vacuum.
Liquid Chromatography/Mass Spectrometry (LC/MS)
Extracts were split into two aliquots, dried, then reconstituted in acidic or basic LC-compatible
solvents, each of which contained 11 or more injection standards at fixed concentrations. A
Waters ACQUITY UPLC and a Thermo-Finnigan LTQ-FT MS were utilized for the analysis.
One aliquot was analyzed using acidic positive ion optimized conditions and the other using
basic negative ion optimized conditions in two independent injections using separate dedicated
columns. Extracts reconstituted in acidic conditions were gradient eluted from a Waters BEH
C18 2.1 x 100 mm, 1.7 μm column using water and methanol both containing 0.1% formic acid,
while basic extracts, which also used water/methanol, contained 6.5 mM ammonium bicarbon-
ate. MS analysis alternated between MS and data-dependent MS2 scans using dynamic
Spaceflight and NAFLD
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exclusion, scanning from 80–1000m/z. Accurate mass measurements were made on precursor
ions with greater than 2 million counts; typical mass error was less than 5 ppm.
Gas Chromatography/Mass Spectrometry (GC/MS)
Extracts destined for GC/MS were re-dried under vacuum desiccation for a minimum of 24 h
prior to derivatization under dried nitrogen using bis(trimethylsilyl)-trifluoroacetamide
(BSTFA). The GC column was 5% phenyl/95% dimethyl polysiloxane fused silica (20 m x 0.18
mm ID; 0.18 μm film thickness) and the temperature ramp was from 40° to 300°C within 16
min; helium was used as the carrier gas. Extracts were analyzed on a Thermo-Finnigan Trace
DSQ fast-scanning single-quadrupole MS using electron impact ionization set to scan from
50–750m/z at unit mass resolving power.
Compound identification
Mass spectral data were loaded into a relational database, where QC limits were imposed.
Peaks were identified using Metabolon’s peak integration software [17]. Compounds were
identified by comparison to library entries of purified standards or recurrent unknown entities
based on the combination of chromatographic properties and mass spectra. Data normaliza-
tion was performed for studies spanning multiple days to correct for variation resulting from
instrument inter-day tuning differences. Each compound was corrected by registering the
medians to equal 1.00 in run-day blocks and normalizing each data point proportionately.
Missing values, assumed to be below the limit of detection of the instrument, were imputed
with the observed minimum after normalization.
Pathway Analysis
Ingenuity Pathway Analysis (IPA) and Exploratory Gene Association Networks (EGAN) [18]
(akt.ucsf.edu/EGAN) were used to assess pathway activation based on changes in mRNA
expression levels. Human Metabolite Database (HMDB) accession numbers were queried and
names of genes associated with metabolites exhibiting changes in concentration were extracted
manually. These genes were used to construct a subset list of genes that may be functionally sig-
nificant, based on metabolomic changes, and this subset was also subjected to pathway analysis
using EGAN.
Microscopy
Raman spectroscopy. Coherent anti-Stokes Raman scattering (CARS) and Stimulated
Raman scattering (SRS) signals were obtained by combining two laser beams: a Stokes beam
fixed at 1064 nm, and a pump beam tuned to the wavelength of interest, described in detail in
S1 File and S1 Table. Spectral tuning of the pump beam was possible by adjusting the crystal
temperature, the Lyot filter, and the cavity length of the OPO with custom-written computer
code. SRS images were obtained by detecting the stimulated Raman loss of the pump beam.
For this purpose, the Stokes beam was modulated at 10 MHz with an acousto-optic modulator
(AOM; Crystal Technology). Additional spontaneous Raman spectra from the mouse liver
were acquired with a commercial Raman microscope (InVia Confocal; Renishaw). Images
were background subtracted using Fluoview software and integrated signal intensity was quan-
tified with ImageJ. Multiple droplets and multiple sections were analyzed from n = 4 mice per
group.
Histology and immunohistochemistry. Fixed tissue sections were processed for hema-
toxylin and eosin (H&E) staining and immunofluorescence microscopy as described previously
Spaceflight and NAFLD
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[19]. Additional histology sections were processed for Periodic Acid Schiff (PAS) [20] and
Picrosirius Red using stains made in house (http://www.ihcworld.com/_protocols/special_
stains/sirius_red.htm). Immunoreactivity for PLIN2 and ACTA2 was visualized using second-
ary antibodies conjugated with Alexafluor 488 or Alexafluor 594 (Life Technologies) at dilu-
tions of 1:500 and 1:250, respectively. Nuclei were stained with 4’, 6-diamidino-2-phenylindole
(DAPI; Sigma Chemical Co.). Antibody to PLIN2 was raised in rabbits as described [21] and
antibody to ACTA2 was purchased from Epitomics-Abcam. Immunofluorescence images were
captured on a Nikon Diaphot fluorescence microscope and digitally deconvolved using the No
Neighbors algorithm (Slidebook) as described previously [19]. Histologic images were captured
on an Olympus BX51 microscope equipped with a 4mp Macrofire digital camera (Optronics)
using the PictureFrame Application 2.3 (Optronics). Cross-polarized light was also used to
enhance visualization of Picrosirius Red stained images as previously described [22]. All images
were cropped and assembled using Photoshop CS2 (Adobe Systems, Inc.).
Second Harmonic Generation (SHG) and Two-Photon Autofluorescence (TPAF)
Microscopy. SHG and TPAF microscopy were used for label-free collagen imaging (see S1
File for details). Cryosections (16 um thick) on microscope slides were rinsed with cold phos-
phate-buffered saline to remove Optimal Cutting Temperature (OCT) solution and cover-
slipped. Sections from n = 3 mice per group were scanned in 2–3 regions of interest. Images
were acquired at 60× and captured using Zen software (Zeiss).
Statistical Analysis
Data were analyzed with GraphPad Prism V6.0 using a Mann-Whitney t-test or unpaired t-
test with Welch’s correction for comparison between groups. Means ± SEM were reported. The
ROUT method with Q = 1% was used to identify outliers for exclusion from analysis. P values
less than 0.05 were selected to indicate significance.
Results
Spaceflight mice lose weight
Muscle atrophy is a well-known complication of exposure to microgravity [23]. Similar to
body weight changes observed in astronauts, mice flown in space lose body mass. We subjected
mice to DXA analysis, both pre- and post-flight, to determine whether spaceflight affected fat
mass as well as lean mass in mice. Table 1 summarizes the DXA results, demonstrating that
both groups of mice lost weight over the 13-day study period. However, FLT mice lost almost
double the amount of weight compared to ground mice (12% of body weight as compared with
6% of body weight lost by AEM controls), although food intake did not significantly differ
between the groups. The composition of weight loss was significantly different between groups;
the FLT mice lost more lean body mass than the AEM controls, and thus exhibited increased
fat as a percentage of body weight. Adipose tissue was collected and weights for inguinal, retro-
peritoneal, perigonadal and brown adipose tissue (BAT) are listed in Table 1. No significant
changes in fat mass were measured between FLT mice and AEM controls. Intact livers were
not weighed prior to dissection and distribution, however liver mass was measured on a com-
parable previous flight, STS-118, where FLT mice exhibited a significant decrease in liver /
brain mass as compared with AEM controls; significance was lost when liver mass was com-
pared with body mass [4].
Notably, FLT mice consumed nearly 20% less water than AEM controls (Table 1). In order
to more comprehensively investigate effects that exposure to the space environment may have
on the liver, including the response to increased concentration of amino acids arising from
atrophied muscle and effects of dehydration, we performed both global transcriptomic and
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metabolomic analyses on liver tissue from FLT mice and AEM controls. Selected genes exhibit-
ing significant changes in mRNA expression levels are presented in Table 2 and the complete
microarray dataset is available on the NASA GeneLab site. Using untargeted metabolomics, we
identified 299 biochemicals (S2 Table), 41 of which had concentrations that were either
increased or decreased in livers of FLT mice with P values reflecting significance (< 0.05) or
above (< 0.1); selected metabolites with increased concentrations are summarized in Table 3.
Mining these data revealed a possible impact of the decreased water consumption of the FLT
mice, shown in Fig 1, where concentrations of choline, choline phosphate and glycerophospho-
choline are decreased, while betaine, an osmolyte produced from metabolism of choline, is
increased in FLT mice. Additionally, mRNA expression of Gpcpd1, a glycerophosphocholine
phosphodiesterase, is significantly increased in FLT mice (log2 FLT/AEM = 1.578, P = 0.0001),
a potential compensatory response.
Spaceflight mice accumulate hepatic lipid droplets
The liver is a key target for metabolic processing of excess lipids. Our measurements of
increased % body fat and decreased hepatic choline led us to investigate whether exposure to
space would target fat accretion in the liver. We therefore used CARS microscopy to image
lipid droplets in livers of AEM controls and FLT mice. CARS is used to visualize and identify
lipids by tuning into resonance with the strong Raman-active vibrational mode at 2845 cm-1,
corresponding to the symmetric stretching vibration of the CH2 portion of fatty acids [24]. As
shown in Fig 2A, and consistent with what we additionally quantified by Oil Red O staining
(2C) and observed using H&E staining (2E), liver cryosections from FLT mice showed signifi-
cant accumulation of hepatic fat (lower panels) whereas those from AEM controls had very
few lipid droplets (upper panels). Quantification of signal intensity from 2–3 regions and two
sections from n = 5 mice per group revealed a ~3.5-fold increase in signal from lipid droplets
in flight mice as compared with AEM controls (2B and D). Total triglycerides were also signifi-
cantly increased in FLT mice as compared with AEM controls (2F).
Table 1. Food intake and body composition measurements for AEM controls and FLTmice.
AEM FLT FLT/AEM P-valueb
Intake
Food Intake (g)a 4.08 ± 0.10 4.09 ± 0.18 1.00 0.865
Water Intake (g) 3.38 ± 0.22 2.73 ± 0.01 0.81 0.038
Body Composition
ΔBody Mass (g)c -1.18 ± 0.24 -2.28 ± 0.57 1.93 0.036
Δ% Fata 4.12 ± 0.77 5.05 ± 1.84 1.22 0.022
Adipose Depots
Inguinal (g) 0.168 ± 0.018 0.144 ± 0.024 0.859 0.447
Retro-peritoneal (g) 0.146 ± 0.022 0.147 ± 0.029 1.00 0.995
Perigonadal (g) 0.411 ± 0.054 0.433 ± 0.082 1.03 0.897
BAT (g) 0.049 ± 0.007 0.034 ± 0.004 0.682 0.092
Values represent mean ± SEM.
aFood and water intakes are calculated based on consumption over the 12.8-day flight for 3 cages of 5 mice in each group and are an estimate of intake
per mouse per day.
bP values are obtained using a two-tailed Student’s t-test comparing AEM and FLT means.
cThe mean change (Final–Baseline) of body mass and % fat from DXA measurements are provided; data are presented from n = 6 mice per group, a
subset of the 15 mice/group that were originally measured, corresponding to the mice from which we received liver tissue.
doi:10.1371/journal.pone.0152877.t001
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Table 2. mRNA expression changes for selected genes.
Entrezid P-value FLT/AEM (log2)
Lipid Droplets
Cidec 14311 3.82E-06 2.501
Pnpla2 66853 9.19E-06 1.436
Plin5 66968 1.13E-05 1.022
Plin4 57435 2.30E-03 0.932
Plin2 11520 8.61E-05 0.782
Plin3 66905 6.47E-04 0.444
Stellate Cell Activation
Lamb3 16780 1.17E-04 0.972
Lepr 16847 1.58E-02 0.787
Serpine1 18787 3.58E-03 0.442
Tgfbr3 21814 7.69E-04 0.423
Tgfbr2 21813 3.54E-03 0.39
Tgfbr1 21812 8.26E-03 0.362
Col3a1 12825 2.94E-02 -0.179
Lama4 16775 2.95E-02 -0.193
Mmp2 17390 3.46E-04 -0.21
Col1a1 12842 1.52E-02 -0.221
Mmp19 58223 3.07E-04 -0.383
Vim 22352 3.65E-01 -0.126
Des 13346 3.82E-01 -0.122
Acta2 11475 2.24E-01 -0.238
Thioesterases
Acot2 171210 1.15E-05 2.055
Acot1 26897 5.06E-06 1.357
Acot5 217698 1.30E-04 1.189
Acot8 170789 1.24E-06 0.856
Ketogenesis
Bdh1 71911 5.95E-04 1.008
Acat1 110446 7.53E-05 0.474
Hmgcl 15356 8.32E-05 0.466
Hadha 97212 6.43E-05 0.314
Triglyceride Biosynthesis
Agpat9 231510 3.20E-06 1.992
Elovl3 12686 4.11E-05 1.865
Lclat1 225010 8.00E-04 0.911
Ppp2r2d 52432 3.49E-05 0.814
Agpat6 102247 7.65E-04 0.508
Elovl1 54325 1.10E-03 -0.473
Elovl6 170439 3.09E-05 -1.308
Retinol Metabolism
Cyp4a31 666168 7.03E-05 1.427
Retsat 67442 7.85E-06 1.049
Hsd17b6 27400 2.47E-02 0.702
Bcmo1 63857 9.18E-03 0.565
Cyp4a32 100040843 2.47E-02 0.514
Lrat 79235 4.68E-03 -0.383
(Continued)
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We next interrogated the multi-‘omics datasets to determine whether triglyceride biosynthetic
pathways are activated by spaceflight, leading to the observed increase in hepatic lipid storage.
Indeed, we found upregulated expression levels of several genes involved in triglyceride biosynthesis
(Table 2). Additionally, expression levels of Plin2, a marker for hepatic steatosis, as well as Plin3
and Plin4, genes thought to mediate formation of nascent droplets [25], were also significantly ele-
vated, suggesting increased synthesis and packaging of triglycerides. However, expression of hepatic
carnitine palmitoyltransferase-1a (Cpt1a), an enzyme involved in transporting fatty acids into the
mitochondria for β-oxidation, was concomitantly upregulated and the concentration of glycerol in
FLTmice was augmented (log2 FLT/AEM = 0.51, P = 0.035; Table 3). Markers of triglyceride lipol-
ysis and lipid droplet metabolism, such as Pnpla2 (Atgl), Plin5 and Cidecwere similarly upregulated
in FLTmice. As noted above, concentrations of choline, choline phosphate and glycerophospho-
choline are decreased in FLT as compared with AEM (Fig 1, S2 Table), perhaps contributing mem-
brane material to surround new or larger triglyceride-packed lipid droplets. Given that total
triglycerides are elevated (2F), these data suggest that spaceflight shifts the balance between lipid
synthesis and oxidation. The end result is increased storage, which we suggest is a protective
response to an excess of toxic lipids overloading mitochondrial oxidative capacity.
Retinoids are lost from spaceflight mouse lipid droplets
The increased hepatic fat in FLT mice observed using CARS and Oil Red O staining led us to
question whether the lipid composition of the droplets in the FLT mice differed from those in
Table 2. (Continued)
Entrezid P-value FLT/AEM (log2)
Cyp2c68 433247 4.47E-03 -0.513
Dhrs3 20148 2.18E-03 -0.521
Cyp2c38 13097 1.97E-02 -0.551
Cyp2c70 226105 6.68E-04 -0.568
Cyp26a1 13082 3.06E-03 -1.114
PPARα targets
Gpd2 14571 6.20E-07 1.476
Fgf21 56636 1.84E-05 1.018
Cd36 12491 1.82E-03 0.868
Slc27A1 26457 2.41E-04 0.673
Ppargc1a 19017 5.69E-02 0.467
Gyk 14933 9.29E-06 0.512
FXR targets and bile acid metabolism
Fgf21 56636 1.84E-05 1.018
Slc22a7 108114 9.75E-03 0.735
Abcg5 27409 2.89E-03 0.614
Baat 12012 8.11E-04 -0.284
Hmgcr 15357 2.62E-02 -0.525
Miscellaneous
Pparg 19016 4.05E-03 0.965
Cpt1a 12894 8.26E-06 0.8
Ucp2 22228 4.53E-02 0.471
Fold changes, P values are calculated using CARMAWeb. P < 0.05 is considered significant. The Entrez
accession number is given by Entrezid.
doi:10.1371/journal.pone.0152877.t002
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the AEM controls. We first used Raman spectroscopy to probe individual droplets. Displayed
in Fig 3 are hyperspectral stimulated Raman scattering (SRS) images excited around the reti-
noid band (1593 cm-1) or the lipid band (2845 cm-1) (left panel) and spontaneous confocal
Raman spectra acquired over a broad spectral range (right panel). Spontaneous confocal
Raman spectra from small lipid droplets did not differ between the two groups; therefore, we
focused on larger droplets that were highly prominent in the FLT mice. The SRS images
showed a dramatic drop of the retinoid signal near ~1593 cm-1 for the FLT mice (3C), which
was not observed in the AEM control mice (3A) when both liver sections were excited at the
same frequency. By contrast, when imaged at the lipid band of 2845cm-1, liver sections of both
AEM (3B) and FLT (3D) mice displayed intense and well-defined lipid droplets suggesting that
the lipid composition of droplets in FLT mice differed primarily in the levels of retinoids pres-
ent within the droplets. These data are recapitulated in the SRS spectra (red curves) plotted in
the panel on the right. Except for the peak at ~1593 cm-1, the SRS spectra are remarkably simi-
lar for the two groups: in the vicinity of the 1593 cm-1 peak, both spectra showed the C = C
stretching mode at 1660 cm-1, characteristic of unsaturated lipids. The C-H stretching band
(2800–3050 cm-1) displayed almost identical signatures for both groups. Additional spontane-
ous confocal Raman spectra (black curves) confirm the similarities throughout the entire spec-
tral range examined (from 1400 to 3100 cm-1). A measurement of lipid unsaturation (ratio
I1660/ I1445) was not significantly different between the groups. The notable difference
between the Raman spectra was the lack of a peak at 1593 cm-1 in the spaceflight mice, which
Table 3. Hepatic metabolites with increasing concentrations in spaceflight.
Biochemical Name FLT/AEM (log2) P-value Sub Pathway
glutarate (pentanedioate) 2.25 0.0001 Lysine metabolism
1-linoleoylglycerol (1-monolinolein) 1.96 0.0562 Monoacylglycerol
3-methylglutarylcarnitine (C6) 1.8 0.0006 Valine, leucine and isoleucine metabolism
3-hydroxybutyrate (BHBA) 1.69 0.0001 Ketone bodies
taurodeoxycholate 1.58 0.05 Bile acid metabolism
cholate 1.38 0.0498 Bile acid metabolism
hydroxyisovaleroyl carnitine 1.36 0.0137 Valine, leucine and isoleucine metabolism
propionylcarnitine 1.29 0.0002 Fatty acid metabolism (also BCAA metabolism)
ophthalmate 1.22 0.013 Glutathione metabolism
dimethylglycine 1.13 0.0019 Glycine, serine and threonine metabolism
hexadecanedioate 1.13 0.0021 Fatty acid, dicarboxylate
stearidonate (18:4n3) 0.99 0.0275 Long chain fatty acid
betaine 0.87 0.0009 Glycine, serine and threonine metabolism
docosapentaenoate (n3 DPA; 22:5n3) 0.86 0.0085 Essential fatty acid
uracil 0.83 0.0175 Pyrimidine metabolism, uracil containing
tetradecanedioate 0.8 0.0043 Fatty acid, dicarboxylate
oleate (18:1n9) 0.77 0.0194 Long chain fatty acid
2-aminobutyrate 0.7 0.0371 Butanoate metabolism
myristoleate (14:1n5) 0.62 0.0482 Long chain fatty acid
linoleate (18:2n6) 0.6 0.0174 Essential fatty acid
corticosterone 0.6 0.0088 Sterol/Steroid
glycerol 0.51 0.035 Glycerolipid metabolism
docosahexaenoate (DHA; 22:6n3) 0.5 0.0435 Essential fatty acid
carnitine 0.48 0.0004 Carnitine metabolism
P < 0.05 is considered significant. P values calculated using t-test with Welch’s correction.
doi:10.1371/journal.pone.0152877.t003
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closely matches the spectral differences seen in the hyperspectral SRS images. The peak at 1593
cm-1 was attributed to the conjugated C = C stretch vibrations of retinol by comparison with a
pure standard (S1 Fig). The relevant vibrational modes and their molecular assignments [26,
27] are detailed in S3 Table.
Expression levels of several HSC activation markers are altered in
spaceflight
Retinoids are primarily stored in HSCs and are exported during activation. Since we observed
an apparent export of retinoids from FLT lipid droplets, we wanted to determine if exposure to
space initiated HSC activation. We first immunohistochemically stained fixed liver tissues for
the presence of PLIN2, a marker for non-activated stellate cells (Fig 4A and 4E) [28]. Inspec-
tion of the sections at 200× magnification revealed PLIN2 staining primarily on lipid droplets
contained within HSC cells; AEM control mice appeared to have more abundant large, non-
membrane bound droplets than livers from FLT mice. We also counted the number of HSCs
containing lipid droplets (non-activated HSC cells) in PLIN2-stained sections from 4 AEM
and 4 FLT mice and found a slight decrease in the FLT animals that failed to reach significance
(FLT/AEM = 0.81, P = 0.22). Lrat expression, required for retinyl ester synthesis and HSC lipid
droplet formation, decreased in FLT mice livers as well (Table 2). To examine activation at the
protein level, we immunohistochemically stained fixed tissues for the presence of alpha-
smooth muscle actin (ACTA2; α-SMA), the canonical marker for activated stellate cells, and
did not observe increased ACTA2 signal with spaceflight (Fig 4A and 4E; shown in red); Acta2
mRNA expression was also not increased (Table 2). There was no difference in expression of
HSC markers vimentin (Vim) and desmin (Des) between the groups suggesting HSCs were not
decreased in FLT mice. We also observed a significant increase in expression of the leptin
Fig 1. Betaine levels are increased in FLTmouse livers.Mass spectrometry-based metabolomics was
performed on n = 6 mice per group as described in Methods and Materials. Mass spectra corresponding to
choline and related metabolites were identified and extracted chromatographic peaks used for relative
quantification. Mann-Whitney analysis of results showed a significant increase in levels of betaine in FLT
mice as compared with AEM controls, with a concomitant decrease in concentrations of metabolic
precursors. *P < 0.05; data are mean ± SEM.
doi:10.1371/journal.pone.0152877.g001
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Fig 2. Spaceflight mice have increased accumulation of hepatic lipid droplets. A) Frozen liver tissue
was cryosectioned using OCT solution and sections imaged by CARS at a magnification of 60×.
Representative images are shown from 3 different animals in each group. Images from AEM ground controls
appear on the top panel and FLT mice on the bottom panel. B) Multiple regions were imaged from 2
cryosections taken at different tissue depths per animal (n = 5/group). Images were processed using ImageJ
Spaceflight and NAFLD
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receptor, Lepr, which when stimulated can promote the myofibroblastic HSC transition. Taken
together, these data suggest there may be fewer non-activated HSC cells in the FLT mice livers
than in the AEM controls; the transition to a fibrogenic phenotype may be initiated for a frac-
tion of the population.
Formation of a fibrotic scar requires both remodeling of the ECM and secretion/organiza-
tion of collagen fibrils. To determine whether fibrosis was occurring, we quantified mRNA
expression levels of a number of collagen genes and found they were either not significantly
changed or were slightly downregulated. We additionally stained fixed tissues from n = 4 mice
per group with Picrosirius Red (Fig 4B and 4F; PS Red) to visualize collagen fibrils. When
viewed with cross-polarized light, the birefringence of the dye bound to the collagen fibers
becomes more apparent, as seen in Fig 4C and 4G. The presence of collagen is most abundant
around central veins (CV) and portal triads (PT), as expected, however fibrils are not readily
observed in other regions of the tissue. Quantification of signal from the birefringent images
did not yield significant differences between the groups (data not shown). We imaged cryosec-
tioned tissues using label-free SHG microscopy. This technique allows for direct visualization
of collagen (particularly fibrillary type I collagen, which tends to generate larger fibers, com-
pared with collagen type III, which forms fine fibrils) in unstained tissue. Fig 4H suggests that
signal from collagen fibers is increased primarily in the sinusoidal regions of FLT livers as com-
pared with the AEM controls (4D). Although collagen formation was not remarkable, tran-
script expression levels for several markers for remodeling of the ECM were altered (Table 2,
Fig 4I). In particular, mRNA expression levels of Serpine1 (PAI-1), a hepatic pro-fibrotic
marker [29], and TGF-β receptor subunits (Tgfbr) 1, 2 and 3 were significantly upregulated,
while that ofMmp2 was decreased. Taken together, these data do not demonstrate the presence
of pathological fibrosis, which would be unlikely following only two weeks of spaceflight. How-
ever, they do show a pattern of upregulation of markers for activation and remodeling of the
ECM that may be indicators for nascent fibrinogenic activity.
Metabolomic and transcriptomic changes in spaceflight mouse livers
suggest activation of PPARα-directed pathways
Retinoids released from activated HSC droplets may be transported by retinol-binding protein
through the bloodstream and taken up by other cells or may act locally. Together with released
fatty acids, retinoids activate transcriptional programs mediated by nuclear receptors impor-
tant in lipid metabolism, such as PPAR and RXR [30]. In order to elucidate potential transcrip-
tional programs that may be affected by exposure to space, we used the subset of significantly
increased metabolites (Table 3) and extracted genes associated with those metabolites from the
HMDB, then performed an enrichment analysis on that gene subset using EGAN. S4 Table
and integrated pixel intensity measured for each unit area. A Mann-Whitney test was used to compare
integrated intensity values between groups. ***P < 0.001. C) Cryosectioned samples were stained with Oil
Red O and imaged at 40× using an Aperio scanner. Sections from AEM and FLT mice were analyzed.
Representative images from 3 mice per group are shown. D) Following color deconvolution, where dark red
staining was used as an indicator of positive lipid signal, the percent of positive lipid signal was calculated per
unit area for samples from n = 5 mice per group. A Mann-Whitney test was used to compare between groups
and the mean ± SEM is shown. ** P < 0.01. E) H&E staining was performed on fixed liver sections from
n = 4–5 mice/group to investigate liver histology. Inspection of the H&E stained sections revealed that the
AEM ground control mice (left panel) had predominantly small zone 2 cytoplasmic lipid droplets (CLD)
whereas the FLTmice (right panel) had an increase in slightly larger CLD in a panlobular pattern. Multiple
lipid droplets are indicated using yellow arrows in representative images from each group. F) Total
triglycerides were measured from n = 6 mice/group using a colorimetric assay (540 nm). A Mann-Whitney test
was used to compare the calculated concentration values between groups. Data shown are mean ± SEM. *
P < 0.05.
doi:10.1371/journal.pone.0152877.g002
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summarizes the top 50 most enriched KEGG pathways and GO process terms associated with
the gene subset corresponding to metabolites with increased concentration in FLT livers. The
majority of genes mapped to metabolic pathways, in particular to fat digestion and absorption.
In addition to fatty acid metabolism, PPAR signaling was also a highly enriched pathway,
involving ~20% of the genes in the subset. We measured the mRNA expression of Ppara by
qRT-PCR and found a significant increase in livers of FLT mice (Fig 5A). We then performed a
functional analysis of PPAR pathways using IPA including the entire transcriptomic dataset,
and genes regulated by PPARα were preferentially activated (Z score = 6.196); indeed, PPARα
was the most significant of the upstream regulators identified. IPA and EGAN analysis of
enrichment of genes with relevant KEGG terms (complete gene set: 72/81 genes observed,
P = 6.4 E-29; 10 genes associated with upregulated metabolites in S4 Table, P = 7.48 E-15)
Fig 3. Lipid droplets in spaceflight mouse liver have reduced retinol content. Stimulated Raman
scattering (SRS) images of liver sections (left panel) revealed a decreased intensity of embedded lipid
droplets at ~1593 cm-1 for spaceflight mice (FLT,C) with respect to ground mice (AEM, A), and showed no
difference at 2845 cm-1 (B, D), the C-H2 symmetric stretching band characteristic of lipids. Hyperspectral SRS
imaging (right panel) around the two frequencies of interest unveil quasi-identical spectra of the lipid droplets
of the two mouse groups, except for the peak at ~1593 cm-1 (red curves). Spontaneous Raman spectra
(black curves) agree with the SRS results. Raman spectra were acquired using n = 3 mice per group, 2
sections per mouse, and 2–3 droplets per section. Technical replicates were also performed for several
samples. SRS imaging was used to confirm the Raman results and was performed on sections from one
mouse in each group.
doi:10.1371/journal.pone.0152877.g003
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shows spaceflight resulted in preferential activation of the PPARα-mediated pathway. We
additionally mapped metabolomics data onto the PPARα pathway. Biomart and GO terms
obtained from AMIGO2 [31] were used to generate lists of genes related to several of these
pathways. Expression of the PPARα activator PGC1-α (Ppargc1a) was increased and an IPA
Upstream Transcription Regulator analysis also showed activation of PGC1-αmediated path-
ways (Z = 3.95). Expression levels of Retsat and Fgf21, other notable PPARα targets were
increased, however expression of HNF4α, another important regulator of hepatic fat metabo-
lism, was unchanged and IPA analysis did not show significant upregulation of HNF4α-modu-
lated pathways. Our data demonstrate a remarkable pattern of increased expression of PPARα-
induced genes important in fatty acid uptake (Cd36 and Slc27a1 [Fatp]), glycerol metabolism
(Gpd2 and Gyk) and thioesterase activity (ACOTs) correlating with spaceflight. Pathways
downstream of PPARγ, ROR and RAR did not appear to be activated.
ACOTs are highly regulated by PPARα and we observed increased mRNA expression levels
of Acot 1, 2, 5 and 8 (Table 2). We therefore focused on mining the transcriptomics and meta-
bolomics data to elucidate the effect of spaceflight-induced modulation of PPARα on thioester-
ase function. In the mitochondria, ACOT2 hydrolyzes fatty acids and has been implicated in
the generation of ketone bodies following stimulation with fenofibrate, a PPARα agonist [32].
We observed a significant elevation in the concentration of the ketone body β-hydroxybutyrate
(Fig 5B, Table 3). Only a slight increase in mRNA expression of ketogenesis genes was observed
in FLT mice and Ucp2, a mitochondrial uncoupling protein, was upregulated (Table 2). In the
cytosol, ACOT1 is thought to play a role in ω-oxidation of fatty acids by CYP4A enzymes acti-
vated by PPARα. We observed a significant increase in the concentration of the dicarboxylic
acids, tetradecanedioate and hexadecanedioate, products of ω-oxidation (Fig 5C, Table 3).
Fig 4. Remodeling of the ECM is increased in livers from spaceflight mice. Fixed tissues were stained for PLIN2 (green) and ACTA2 (red) and nuclei
were stained with DAPI (blue) to visualize lipid droplets and markers of activation in stellate cells (A, E). Mouse liver tissues were either fixed as described in
Materials and Methods and stained with Picrosirius Red (B, C, F,G) or flash frozen and cryosectioned (D, H). Collagen staining was observed in Picrosirius
Red stained sections (B, F) primarily near the portal triad (PT) and central vein (CV) areas. Using cross-polarized light, signal was more readily observed (C,
G). SHG imaging was performed on cryosectioned samples (D, H) and increased collagen signal in interstitial regions was observed in livers from FLTmice
as compared with AEM controls. Representative images are shown from each group (n = 3–5 mice/group). Magnification is 200× for stained samples and
60× for SHG images. Transcriptomic analysis reveals that expression levels of several important modulators of ECM remodeling are changed in spaceflight
(I). Values are mean ± SEM; * P < 0.05. n = 5–6 / group.
doi:10.1371/journal.pone.0152877.g004
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Glutaryl-coA is a substrate for ACOT8 and elevated glutarate was detected in FLT mice
(Table 3). In the peroxisome, ACOT8 regulates secretion of free and conjugated bile acids. We
observed a significant FLT-related increase in the concentration of cholate (Fig 5D, Table 3)
whereas Hmgcr expression was downregulated (Table 2) and precursor hepatic cholesterol lev-
els were unchanged (S2 Table). Expression levels of Abcg5/8, key genes involved in the export
of cholesterol and biliary sterols, are upregulated; however, expression of the bile salt export
pump Abcb11 was decreased and the uptake transporter Slc22a7 increased (Table 2). The con-
centration of glycocholate was significantly decreased (Fig 5D, Table 3), concomitantly with
downregulated expression of Baat, a gene responsible for glycine conjugation of bile acids
(Table 2). Taken together, these data suggest spaceflight modulates cholesterol and bile acid
metabolism, resulting in a net accumulation of deconjugated bile acids in the liver. We did not
have access to blood to measure serum cholesterol levels or bile acids, nor did we have access to
intestines to measure intestinal bile acids, therefore our data are limited and only reflect
changes in hepatic bile acid pools. Although Shp and Cyp7A1mRNA expression levels were
not elevated, pathway analysis showed activation of some FXR-mediated pathways (S2 Fig)
Fig 5. Products of PPARα-mediated thioesterase activity are upregulated in spaceflight mice. A)
Hepatic PPARαmRNA expression was quantified using qRT-PCR and normalized to 18S rRNA levels for
both FLT mice and AEM controls. An unpaired t-test with Welch’s correction was used for comparison.
PPARα targets include acyl-coA thioesterases, which act in different cellular compartments to mediate lipid
metabolism. Mass spectrometry-based metabolomics analysis of liver compounds showed increased
concentrations of products of B) ACOT2,C) ACOT1 and D) ACOT8 activity. Data (mean ± SEM) were plotted
for n = 3–5 mice/group.
doi:10.1371/journal.pone.0152877.g005
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and mRNA expression of Fgf21, a target of both PPARα and FXR, was highly upregulated in
FLT mice (Table 2). Taken together, these data demonstrate a spaceflight-induced increase in
activity of PPARα-driven pathways, particularly those mediated by ACOTs.
Fatty acids are natural ligands for PPARs, therefore fatty acid profiles from the metabolo-
mics data were compared between AEM and FLT mice to investigate potential activators of
PPARα signaling. Fig 6 summarizes concentrations of fatty acids obtained using mass spec-
trometry, grouped into medium and long chain saturated fatty acids (MCSFA, LCSFA), mono-
unsaturated fatty acids (MUFA) and ω-6 and ω-3 polyunsaturated fatty acids (ω-6/ω-
3-PUFA). Heat maps show the relative concentrations of the individual fatty acids for both
AEM and FLT (n = 5/group), plotted in S3 Fig. One-way ANOVA test with multiple compari-
sons between the five groups for AEM and FLT revealed that the concentrations of ω-3 fatty
acids were significantly different than all other groups and t-test with Welch’s correction con-
firmed that ω-3 fatty acids were preferentially elevated in spaceflight. The ω-3/ω-6 ratio was
increased by ~ 26% in spaceflight mouse livers as compared with ground controls. The ω-6/ω-
3 ratio in the NASA foodbar given to both groups was 10 [13]. Notably, our metabolomics
results show significant increase in docosahexaenoate (DHA; 22:6n3) in spaceflight (log2 FLT/
AEM = 0.5, P = 0.043; Table 3).
Discussion
Spaceflight enhances fat accumulation in the liver
Despite adequate intake of energy and protein by astronauts, spaceflight results in catabolism
of lean body mass in a flight duration-dependent manner and an increase in body fat [1]; body
weight alone does not account for changes in energy balance. Our DXA measurements show-
ing a 22% increase in the fat to body weight ratio in FLT mice as compared with ground con-
trols are consistent with human spaceflight and bed rest studies, as is the apparent atrophy of
muscle mass [33]. We measured an increase in total hepatic triglycerides; more lipid droplets
were visualized using CARS and Oil Red O staining and genes involved in triglyceride biosyn-
thesis were upregulated in FLT mice as compared with AEM controls. Packaging the lipids into
droplets may protect the mitochondria from lipotoxicity when β-oxidation is overloaded or
impaired and expression of genes involved in lipid droplet formation (Plin3 and Plin4) and
Fig 6. Increasedω-3 polyunsaturated fatty acid concentration following spaceflight.Mass
spectrometry-based metabolomics was performed and spectra corresponding to both saturated and
unsaturated fatty acids were identified and chromatographic peaks quantified. Mann-Whitney analysis of
results from n = 5 mice per group showed a significant increase in levels ofω-3 PUFAs in spaceflight mice as
compared with AEM controls. **P < 0.01; data are mean ± SEM.
doi:10.1371/journal.pone.0152877.g006
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growth (Cidec) were indeed elevated. However, expression levels of genes involved in lipid
droplet lipolysis (Plin5; [34–36]), triglyceride lipolysis (Pnpla2; Atgl) and β-oxidation (Cpt1a)
were also upregulated. We postulate that lipid turnover is increased in the livers of FLT mice,
with enhanced “anabolic”mechanisms such as fatty acid transport offsetting “catabolic”mech-
anisms such as lipolysis, resulting in a net retention of lipids. Although decreased choline has
been linked with fatty liver [37], it is more likely that the relative dehydration of the FLT mice
led to the increased production of the osmolyte betaine at the expense of choline and related
metabolites, contributing to the dynamic metabolism of the glycerophospholipid membranes
surrounding the lipid droplets.
Spaceflight may induce initiation of HSC activation
We sought to determine whether compositional differences existed between lipid droplets in
livers of FLT mice vs. AEM controls. We used spontaneous confocal Raman spectroscopy and
found notable chemical differences between FLT and AEMmice at 1593 cm-1 in the Raman
spectra. This component had a negligible effect on the CH band; it did not affect the 3010 cm-1
peak (= C-H) and the unsaturation ratio (I3010/I2850) did not change between AEM and FLT
mice. A strong candidate for this chemical component is the highly conjugated dietary fatty
acid retinol (Vitamin A), present in the NASA foodbar given to both groups [12, 13, 38]. Reti-
nol is almost exclusively stored in HSC lipid droplets and is released when HSCs are initially
activated [39–41]. The significant increase in LeprmRNA expression, a marker for HSC activa-
tion and differentiation [42], combined with the loss of retinoids, suggests nascent HSC activa-
tion occurs in the FLT mice. HSC lipid droplets can either be smaller droplets bounded by a
membrane or larger, membrane-free droplets [43] and reduced droplet size correlates with
HSC activation and loss of retinoids [44]. The most marked differences in the retinol peak
occurred in the largest droplets (AEM livers with the largest droplets had the most retinol sig-
nal) and livers of AEMmice had more HSCs containing membrane-free lipid droplets, again
supporting the potential for early-stage HSC activation. Remarkably, altered retinol levels and
concomitant fatty liver was observed in rats subjected to 14 days of hindlimb suspension, the
“gold standard” ground-based spaceflight analog for microgravity [45].
Activated HSCs transform to proliferating myofibroblasts, secreting collagen and remodel-
ing the ECM. We did not see increased mRNA expression of Acta2 and collagen genes, which
are late stage markers of HSC activation. Immunohistochemistry of ACTA2 also did not show
differences between the groups. Notably, PPARγ expression was significantly increased.
PPARγ expression is negatively correlated with ACTA2 [46], which may potentially explain
why we observed loss of retinol without a concomitant increase of ACTA2. Since HSCs are
only a small percentage of total hepatic cellular content, it is also possible that changes in
expression of some markers in HSCs are masked by expression levels in other cell types. We
did, however, observe upregulation in expression of Serpine1 and Tgfbr subunits and downre-
gulation ofMmp2, markers of ECM remodeling.
We did not observe significant changes in the number of collagen fibrils between the groups
by Picrosirius Red staining. Interestingly, more collagen fibrils are observed in FLT mice livers
using SHG imaging; this technique may be more sensitive to different fibril types and more
work needs to be done to optimize measurement of these nascent fibrils. Increase in fibrosis in
rodents occurs following an extended period of insult [47, 48] and ~13 days of exposure to
microgravity is unlikely to induce pathology, particularly for rodents where hepatic pathologic
outcomes are not as severe as those observed in humans [47]. However, it is possible that we
are observing the genesis of liver insult and that significantly longer duration exposure to
stressors in space will result in increases in some of these markers. Interestingly, expression of
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pro-fibrotic genes was increased in mouse lung tissue after similar duration spaceflight, and
histology showed pro-fibrotic changes as well [49], supporting the notion of short-duration
spaceflight initiating a nascent fibrogenic response.
Retinoid metabolism and DHA biosynthesis may modulate HSC
activation
Following export from HSCs, protein-bound retinoids may be transported systemically, taken
up by other cells, and metabolized to bioactive isoforms (as reviewed [30]. Hormonal retinoids,
such as all-trans or 9-cis retinoic acid (atRA and 9cRA, respectively), regulate expression of tar-
get genes via activation of retinoic acid receptors (RAR) and retinoid X receptors (RXR) [50].
RXR heterodimerizes with RAR, PPARs, FXR and liver X receptors (LXR), nuclear receptors
responsible for regulating glucose and lipid metabolism. We mapped our transcriptomics data
onto the KEGG pathway for retinol metabolism to attempt to elucidate the fate of retinoids
that may be exported from HSCs and retained in the liver. As summarized in Table 2, mRNA
expression of the PPARα target Retsat was highly upregulated in the FLT mice. Retsat catalyzes
the production of all-trans-13,14-dihydroretinol (DROL), a ligand for RARs and a weak analog
of atRA [51]. Additionally, Cyp26a1 expression was significantly downregulated. CYP26, an
RAR target, specifically hydroxylates atRA, converting it to isomers with little affinity for
nuclear receptors, and also has a role in clearing bioactive retinoids [52]. Taken together, the
transcriptomics data suggest upregulation of atRA deactivation pathways [53], a potentially
protective response to elevated bioactive retinoid levels following HSC activation. These data
did not show highly significant upregulation of genes involved in the metabolism of retinol to
9cRA, a putative RXR ligand.
Supporting the notion of a protective or compensatory response to HSC activation is the
increased concentration of hepatic DHA we observed, which is correlated with retinol loss
[54]. DHA and arachidonic acid bind RXRα and are activating ligands [9] and increased RXRα
expression inhibits HSC activation and suppresses markers of fibrosis in rats [55]. The combi-
nation of PPAR, RAR and RXR agonists was shown to be protective against activation in rat
HSCs [56]. Taken together, our results suggest that DHA biosynthetic pathways may be upre-
gulated in spaceflight concomitant with retinol loss as a compensatory response to protect
HSCs from activation, or to maintain homeostasis. In some studies, retinoids induce hypertri-
glyceridemia and hepatic lipogenesis whereas in others, excess atRA leads to increased β-oxida-
tion [57]. Although protective deactivation pathways may be upregulated, exposure to
spaceflight appears to paradoxically induce both hypertriglyceridemia and increased β-oxida-
tion, which may be a protective response to lipotoxicity. It will be important in the future to
work out mechanistic details of these interactions using ground-based models such as hind-
limb unloading.
PPARα-mediated pathways are activated in livers of FLT mice
PPARα, fatty acids and retinoids regulate an overlapping set of target genes that impact a vari-
ety of functions including fatty acid uptake and intracellular binding, mitochondrial β-oxida-
tion and peroxisomal fatty acid oxidation, ketogenesis, triglyceride turnover and bile synthesis/
secretion [58, 59] and PPARα expression was significantly upregulated in FLT mice. ACOTs
are thioesterases (and PPARα targets) that play important roles in fatty acid metabolism,
engaging in hydrolase, carboxyesterase and lipase activity [60, 61]. ACOT activity may control
the pool of NEFAs transported to the nucleus available for activating PPARα [62] which regu-
lates their transcription [63], suggesting existence of a self-maintaining loop allowing modula-
tion of PPAR signaling [64].
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Cytoplasmic ACOT1, together with CYP4, mediates increased ω-oxidation and the genera-
tion of dicarboxylic acids [63], a rescue pathway when β-oxidation is impaired or overloaded
[65] and oxidative stress is increased. We observed up-regulation of Cyp4a31mRNA expres-
sion levels and significant increases in products of ω-oxidation, supporting activation of this
PPARα-modulated pathway in spaceflight. Localized to the mitochondria [66], ACOT2 activity
is linked to increased fatty acid oxidation, as well as elevated ketogenesis, levels of NEFAs and
liver triglycerides [63]. Increased expression of Acot2 and β-hydroxybutyrate without concomi-
tant upregulation of canonical ketogenesis genes in FLT mice support a spaceflight-induced
increase in fatty acid oxidation as well as the potential for a more direct role of ACOT2 in keto-
genesis that may be regulated by PPARα.
ACOT8 is a type II thioesterase localized to the peroxisome; over-expression may inhibit
peroxisomal β-oxidation to such an extent that hepatic lipids accumulate in droplets [66].
ACOT8 mediates the generation of free bile acids formed from metabolism of cholesterol [63];
we not only observed increased cholate but also a hydrophobic shift in the composition of the
bile acid pool (increased cholate and decreased glycocholate) due to decreased Baat expression
[67]. Increased bile acid hydrophobicity may result in hepatic alterations and tissue injury [68].
Notably, both cholate and DHA are FXR activating ligands [69] and increased Fgf21 expression
is a marker for FXR activation [70]. FXR and bile acids have emerged as important regulators
of liver metabolism, affecting lipid and glucose homeostasis as well as hepatic inflammation (as
recently reviewed [69, 71, 72]) and FXR activation protects murine livers from HSC activation
and fibrosis [73]. Although canonical FXR signaling does not appear to be activated (Shp and
Cyp7A1 expression levels are not upregulated), our data suggest the potential for cross-talk
between PPAR and FXR pathways and spaceflight-induced activation mediated by DHA, as
modeled in Fig 7. More long-term studies, with comprehensive analyses of total bile acid pools,
are needed to determine whether increased exposure to the space environment will result in
frank hepatic injury.
Conclusions
We have demonstrated that spaceflight results in increased hepatic triglyceride storage along
with a loss of retinoids from HSC lipid droplets. Mining data from multi-‘omics experiments
helped to explain these observations and develop the hypothesis that spaceflight, viaHSC and
thioesterase activation, induces and maintains PPARα-mediated pathways, leading to early
NAFLD. Although the data are preliminary, we are intrigued by the possibility of spaceflight-
mediated modulation of FXR signaling and its potential compensatory role in protection from
nascent HSC activation. A notable caveat of this study is that these mice were returned to Earth
prior to tissue harvest, therefore the stress of re-entry and acclimatization must be considered
when evaluating these data. Mobilization of NEFAs from adipocytes can result from a response
to stress. On the other hand, a state of chronic stress, particularly when energy is not used, such
as in the spaceflight environment, can result in a hormonal shift, altering metabolic homeosta-
sis [74]. Mice have not yet been sampled in microgravity; it is possible they suffer from chronic
stress during spaceflight, however it is possible that exit and reentry are the stressors. The adult
liver is a primary regulator of lipid homeostasis, and as such it carries out multiple metabolic
processes; the observations described here will clearly influence development of necessary
countermeasures to protect astronaut health on long-duration spaceflights such as a mission to
Mars (or for individuals on Earth confined to bedrest for long periods of time). Further study
in this area is merited and analysis of tissues harvested in space from mice flown aboard the ISS
for several months may help determine whether long-term spaceflight might lead to hepatic
injury and whether damage can be prevented.
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Supporting Information
S1 Fig. A dominant peak corresponding to a Raman shift near 1593 cm-1 is observed for
retinol. A Raman spectrum of a pure retinol standard shows the presence of a major peak at
1593 cm-1. The high wavenumber region of the spectrum (inset) is also markedly different
than that obtained in tissue samples.
(PDF)
S2 Fig. Pathway analysis of FXR signaling. IPA analysis was performed using no fold cutoff
and P = 0.1 on the entire gene set. Pathways for cholesterol secretion were activated, as well as
those promoting hepatic bile accretion. Red indicates upregulated expression; green indicates
downregulated expression in FLT mice as compared with AEM control animals. The intensity
of color correlates with magnitude of up or downregulation.
(PDF)
S3 Fig. Concentration heat map of fatty acids. Concentrations for fatty acids identified by
metabolomics are displayed as a heat map for n = 6 mice per group. Green shading indicates a
negative value for log2 FLT/AEM concentration values (down-regulated), while red indicates a
Fig 7. Spaceflight induces activation of PPARα pathwaysmaintained by a feedback loop involving
hepatic thioesterase activity andmediated by DHA. Elements of the space environment such as
microgravity, oxidative stress and radiation may lead to activation of the PPARα-RXRα heterodimer byω-3
fatty acids (including DHA), PGC-1α and retinoids from activated HSCs, increasing thioesterase activity.
Hepatic steatosis, as well as synthesis of bile acids, ketone bodies and dicarboxylic acids, results from
activation of downstream pathways. Fibrosis may also ensue from transformation of the activated HSCs.
DHA and bile acids are ligands for FXR, which may be activated in a compensatory manner and help protect
from HSC-induced remodeling of the ECM. PPRE, peroxisome proliferator response element.
doi:10.1371/journal.pone.0152877.g007
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ω-3 PUFAs, particularly DHA, DPA and EPA.
(PDF)
S1 File. Supplemental methods.
(DOCX)
S1 Table. Pump wavelengths corresponding to the Raman shifts of interest for CARS imag-
ing, and SRS hyperspectral interrogation at the C-H stretching band and at the higher fre-
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